Crocus sativusL. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study
Author(s) -
Sara Baziar,
Ali Aqamolaei,
Ebrahim Khadem,
Seyyed Hosein Mortazavi,
Sideri,
Erfan Sahebolzamani,
Amirhosein Mortezaei,
Shakiba Jalilevand,
Mohammad-Reza Mohammadi,
Mahsa Shahmirzadi,
Shahin Akhondzadeh
Publication year - 2019
Publication title -
journal of child and adolescent psychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.935
H-Index - 84
eISSN - 1557-8992
pISSN - 1044-5463
DOI - 10.1089/cap.2018.0146
Subject(s) - methylphenidate , crocus sativus , attention deficit hyperactivity disorder , randomized controlled trial , rating scale , medicine , psychiatry , adverse effect , pediatrics , psychology , traditional medicine , developmental psychology
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neuropsychiatric disorders of childhood and adolescence. About 30% of patients do not respond to stimulants or cannot tolerate their side effects. Thus, alternative medication, like herbal medicine, should be considered. The aim of this trial is to compare the safety and efficacy of Crocus sativus (saffron) versus methylphenidate in improving symptoms of children with ADHD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom